Health professionals say early diagnosis and treatment are critical for those who develop symptoms from the infection.
In 2021, an estimated 6.6 percent of U.S. adults were immunosuppressed. The estimate was 2.7 percent in 2013.
One study shows that even the most vulnerable populations can clear the COVID-19 virus within a couple weeks rather than several months.
Genetically modified stem cells will be injected into the child’s bloodstream to build a new functional immune system, researchers say.
Health professionals say early diagnosis and treatment are critical for those who develop symptoms from the infection.
In 2021, an estimated 6.6 percent of U.S. adults were immunosuppressed. The estimate was 2.7 percent in 2013.
One study shows that even the most vulnerable populations can clear the COVID-19 virus within a couple weeks rather than several months.
Genetically modified stem cells will be injected into the child’s bloodstream to build a new functional immune system, researchers say.